Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.
about
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsOnto better TRAILs for cancer treatmentIntegrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and oldA multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screeningApplying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometryMultiple marker detection in peripheral blood for NSCLC diagnosisElevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.Application of proteomics to cancer early detectionLung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumRole of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.Biomarkers in cancer micrometastasis: where are we at?Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.New biomarkers for lung cancer.Lung cancer screening: review and performance comparison under different risk scenarios.Dysplasia and cancer screening in 21st century.Increased risk of cardiovascular disease in premenopausal female ragpickers of Eastern India: involvement of inflammation, oxidative stress, and platelet hyperactivity.Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.Assessment by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry of the Effects of Preanalytical Variables on Serum Peptidome Profiles Following Long-Term Sample Storage.[Evaluation of serum cytokines in small cell lung cancer and its clinical significance].Metabolome-based biomarkers: their potential role in the early detection of lung cancer
P2860
Q24628852-60FC63EF-1B09-45A5-918D-A79FBE6818F8Q26768160-CB0E8D1F-4A60-4471-9BFA-FDCDB12CB1A3Q28396741-505B5DCB-3A15-45DE-86C3-82882C2A1EABQ30511822-12E61D78-F4A0-4922-9714-2B053746A9FFQ33846310-D6F0AD37-B988-4AB2-85ED-2D405E05E71FQ34077576-B80D988F-F068-4EB0-A1A9-E3A3069B6890Q34612077-A27F5C9B-40CF-4CA9-A769-56047C815B47Q35008957-117FC6BC-DCD2-4D2C-BE11-EF2862FD2F47Q35053031-0D7C49CA-0671-463D-A384-E34861C48C7EQ35090585-02062CCB-8A18-4B3E-B509-B5A4D131F08CQ35853714-99608E8B-B1C5-48EC-9F50-02ECC8DE33B0Q35957217-4D110D28-E98D-474C-BC65-E807F8B3DB02Q36960001-10518425-BBF5-4E99-8CEA-9C80140DB86AQ37745870-D5BC13CE-CBC4-4ACD-AD77-0E5E632D1891Q37810222-5711DB19-1F32-4843-8736-F943B6563166Q37848663-003E86B1-A4B6-4181-8C16-B3FF6A91BA0BQ38089079-9CE88612-C536-4BE7-A307-A68666ABE1C1Q38155065-EBEDEA0F-3093-4B16-A763-03280543115BQ38218654-308E636D-6DF6-4E84-9B1A-0AD66C41248DQ40649053-751027D5-C265-4DE0-A553-8C12E164011BQ42646980-3613FF9E-985C-4B93-97FA-225EC901450FQ46302493-01BE2654-72E6-4FD0-9CA9-30E570D29C1AQ47558061-917B38FB-9744-47EE-840E-A1F49EA7053DQ47681877-1236F4B5-0761-43E8-9814-41E1881448E9Q48120088-EB1D382C-D377-4003-8F19-87ED1B0ED794Q49931504-0551BF51-0620-46B5-9983-4EEBFD1E4544Q55424130-A20A7827-2F3B-40DA-B9E1-FCC4DA4C005CQ59129088-1CAB76DC-19B5-46D0-9FA2-E09CD6B1D217
P2860
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Connective tissue-activating p ...... r early lung cancer detection.
@en
Connective tissue-activating p ...... r early lung cancer detection.
@nl
type
label
Connective tissue-activating p ...... r early lung cancer detection.
@en
Connective tissue-activating p ...... r early lung cancer detection.
@nl
prefLabel
Connective tissue-activating p ...... r early lung cancer detection.
@en
Connective tissue-activating p ...... r early lung cancer detection.
@nl
P2093
P2860
P356
P1476
Connective tissue-activating p ...... or early lung cancer detection
@en
P2093
Annette McWilliams
Jennifer Kondra
Michael Kuzyk
S F Paul Man
Stephen Lam
P2860
P304
P356
10.1200/JCO.2008.19.4233
P407
P50
P577
2009-05-04T00:00:00Z